BioSpace News Archive

Genetown

Renovia Supports ACOG and WPSI Recommendations Related to Screening for Urinary Incontinence

Renovia is Developing a Product Pipeline to Better Diagnose and Treat Women Affected by Pelvic Floor Disorders, including Urinary Incontinence

August 28, 2018
·
4 min read
Genetown

AVEO Oncology to Participate in Upcoming September 2018 Conferences

AVEO Pharmaceuticals, Inc. (Nasdaq: today announced that Michael Bailey, president and chief executive officer, will participate in the following investor conferences:

August 28, 2018
·
3 min read
Biotech Bay

BioTime’s CEO Adi Mohanty and CFO Russell Skibsted to Participate in Upcoming Panel and Conferences

Adi Mohanty to participate in panel discussion at the Annual B. Riley FBR Healthcare Conference

August 28, 2018
·
4 min read
Aurinia Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018

Aurinia Pharmaceuticals Inc. today announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC.

August 28, 2018
·
1 min read
LimaCorporate Awarded With Two New ODEP Ratings for Physica ZUK

LimaCorporate is proud to announce that another milestone has been reached following the SMR Reverse ODEP Ratings in March 2018. Physica ZUK has been awarded by the Orthopaedic Data Evaluation Panel (ODEP) in the UK with the following two ratings (latest ODEP ratings can be found at www.odep.org.uk

August 28, 2018
·
3 min read
Business

Alimera Sciences to Present at the Annual B. Riley Healthcare Conference

Dan Myers, Chief Executive Officer, will be presenting at the annual B. Riley Healthcare Conference taking place September 4th, 2018 at the Marriott East Side in New York, New York.

August 28, 2018
·
1 min read
Biotech Beach

Viking Therapeutics to Participate in Upcoming Investor Conferences

The company will participate in three upcoming investor conferences.

August 28, 2018
·
2 min read
Biotech Beach

Stellar Biotechnologies to Present at H. C. Wainwright Global Investment Conference

20th Annual Global Investment Conference to be held September 4-6, 2018 in New York City.

August 28, 2018
·
3 min read
Business

Catalent, Inc. Reports Fourth Quarter Fiscal 2018 Results

Q4'18 revenue of $685.3 million increased 11% as-reported, or 9% in constant currency from the prior-year period.

August 28, 2018
·
34 min read
Policy

European Commission Designates OMS721 as an Orphan Medicinal Product for Treatment in Hematopoietic Stem Cell Transplantation

Omeros Corporation (Nasdaq: OMER) today announced that the European Commission (EC) has adopted a decision designating OMS721 as an Orphan Medicinal Product in the European Union (EU) for treatment in hematopoietic stem cell transplantation (HSCT).

August 28, 2018
·
6 min read